Beclometasone hydrofluoroalkane inhalation - 3M

Drug Profile

Beclometasone hydrofluoroalkane inhalation - 3M

Alternative Names: Beclometasone dipropionate hydrofluoroalkane inhalation - 3M; Beclometasone HFA inhalation - 3M; Beclometasone pressurised metered-dose inhalation - 3M; Beclomethasone breath-activated inhalation - 3M; Beclomethasone dipropionate hydrofluoroalkane inhalation - 3M; Beclomethasone HFA inhalation - 3M; Beclomethasone hydrofluoroalkane inhalation - 3M; HFA-134a BDP; Hydrofluoroalkane-134a beclomethasone dipropionate; Junik; Nexxair®; Qvar; Qvar Autohaler; Qvar BAI; Qvar Easi-Breathe; Qvarspray; Ventolair

Latest Information Update: 12 Nov 2016

Price : $50

At a glance

  • Originator 3M Pharmaceuticals
  • Developer 3M Pharmaceuticals; Teva Branded Pharmaceutical Products R&D
  • Class Antiallergics; Antiasthmatics; Chlorinated steroids; Corticosteroids; Pregnadienetriols; Small molecules; Vascular disorder therapies
  • Mechanism of Action Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Asthma

Most Recent Events

  • 01 Mar 2016 Teva completes a phase-III trial in Asthma (In children) in USA, El Salvador, Panama, Israel, Mexico, Poland, Croatia and Ukraine (Inhalation) (NCT02040766)
  • 01 Mar 2016 Teva Branded Pharmaceutical Products, R&D completes a phase III trial for Asthma (In adolescents, In adults) in USA (Inhalation) (NCT02513160)
  • 06 Feb 2015 Launched for Asthma in Belgium, Greece, Netherlands, Portugal, Switzerland, South Africa, Israel, Malaysia and Thailand (Inhalation) prior to February 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top